The Company has entered a trading halt pending an announcement of results from its European clinical trials of BNC210, a compound aimed at providing relief from anxiety disorders.
![]()
Looks like a good bet...
![]()
The Company has entered a trading halt pending an announcement...
Add to My Watchlist
What is My Watchlist?